Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05050448 · ClinicalTrials.gov registry record · Phase 1
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
A Phase 1 study of Knee Osteoarthritis, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT05050448 is a Phase 1 study of Knee Osteoarthritis that has completed, run by ZetrOZ. The registered enrollment target is 60 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05050448, a Phase 1 study of Knee Osteoarthritis, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the usability of the ultrasound devices and common pain relief gel. The ability of the three treatment approaches to reduce pain, stiffness, and functionality as measured by NRS scale and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) will be evaluated.
Conditions Studied
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DRUG 1% Diclofenac Topical Gel
Study Locations (3)
Connecticut
- Orthopaedic Foundation - Stamford
- ZetrOZ Systems - Trumbull
New York
- Cayuga Medical Center - Medical Pain Consultants - Dryden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05050448
The ClinicalTrials.gov registry entry for NCT05050448 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (80% lower). The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT05050448 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, New York.
Frequently Asked Questions
What is clinical trial NCT05050448 about?
NCT05050448 is a clinical study titled "Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain". The purpose of this study is to evaluate the usability of the ultrasound devices and common pain relief gel. The ability of the three treatment approaches to reduce pain, stiffness, and functionality as measured by NRS scale and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) w...
What is the current status of trial NCT05050448?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-08-01. Estimated completion is 2022-12-31.
What conditions does trial NCT05050448 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT05050448?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), 1% Diclofenac Topical Gel (DRUG).
Who is sponsoring clinical trial NCT05050448?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05050448 being conducted?
This trial has 3 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
COMPLETED · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.